Craig E.  Samitt net worth and biography

Craig Samitt Biography and Net Worth

In his role as president and chief executive officer of Blue Cross and Blue Shield of Minnesota and its parent company Stella, Dr. Craig E. Samitt is responsible for overseeing the strategy and operations of the state’s first and largest health plan.

Dr. Samitt came to Blue Cross in July 2018 from Anthem, Inc., where he served as executive vice president and president of their Diversified Business Group. He built partnerships within and outside of Anthem to provide new sources of growth for the enterprise and deepened Anthem’s relationships and impact across the healthcare ecosystem. Concurrently, he led and executed a nationwide clinical vision and strategy as Anthem’s chief clinical officer. Dr. Samitt’s numerous accomplishments at Anthem include advancing the company’s portfolio of provider partnerships and payment innovation models, leading quality improvements in patient outcomes and increasing the delivery of value-based care.

An internal medicine physician by training, Dr. Samitt has worked across multiple sectors within the health care industry. His career includes a number of senior executive positions, including partner and global provider practice leader at Oliver Wyman; president and CEO of HealthCare Partners, a subsidiary of DaVita HealthCare; and president and CEO of Dean Health System Inc., one of the largest integrated health systems in the Midwest.

For nearly 25 years, Dr. Samitt has been a nationally recognized expert and thought leader on health care delivery and policy. His record of collaborating across the health care system to deliver higher quality care at a lower cost led to him being named as one of the “50 Most Influential Physician Executives and Leaders” by Modern Healthcare in 2018.

Dr. Samitt currently serves on multiple boards, including the National Committee for Quality Assurance; the Blue Cross Blue Shield Association; the National Institute for Health Care Management Foundation; Minnesota Business Partnership; the Minnesota Council of Health Plans; Twin Cities Habitat for Humanity; the Medical Alley Association; and BCS Financial Corporation. Additionally, he is member of the editorial advisory council for FierceHealthcare publications. Dr. Samitt is a former commissioner of the Medicare Payment Advisory Commission (MedPAC), an independent agency that advises Congress on Medicare payment policy.

Dr. Samitt holds an undergraduate degree from Tufts University, a medical degree from Columbia University and an MBA from the Wharton School of Business. He completed a medical residency in internal medicine at Brigham and Women’s Hospital in Boston and is a fellow of the American College of Physicians.

What is Craig E. Samitt's net worth?

The estimated net worth of Craig E. Samitt is at least $10.84 million as of July 26th, 2018. Samitt owns 20,857 shares of Elevance Health stock worth more than $10,843,554 as of March 28th. This net worth evaluation does not reflect any other investments that Samitt may own. Learn More about Craig E. Samitt's net worth.

How do I contact Craig E. Samitt?

The corporate mailing address for Samitt and other Elevance Health executives is 220 VIRGINIA AVENUE, INDIANAPOLIS IN, 46204. Elevance Health can also be reached via phone at (800) 331-1476 and via email at [email protected]. Learn More on Craig E. Samitt's contact information.

Has Craig E. Samitt been buying or selling shares of Elevance Health?

Craig E. Samitt has not been actively trading shares of Elevance Health in the last ninety days. Most recently, Craig E. Samitt sold 19,541 shares of the business's stock in a transaction on Thursday, July 26th. The shares were sold at an average price of $246.68, for a transaction totalling $4,820,373.88. Following the completion of the sale, the executive vice president now directly owns 20,857 shares of the company's stock, valued at $5,145,004.76. Learn More on Craig E. Samitt's trading history.

Who are Elevance Health's active insiders?

Elevance Health's insider roster includes Gail Boudreaux (CEO), Robert Dixon, Jr. (Director), John Gallina (CFO), Brian Griffin (CEO), Peter Haytaian (EVP), Julie Hill (Director), Charles Kendrick, Jr. (EVP), Gloria Mccarthy (EVP), Ronald Penczek (CAO), Ramiro Peru (Director), Craig Samitt (EVP), Ryan Schneider (Director), Joseph Swedish (Insider), Jose Tomas (EVP), and Thomas Zielinski (EVP). Learn More on Elevance Health's active insiders.

Are insiders buying or selling shares of Elevance Health?

In the last year, insiders at the sold shares 3 times. They sold a total of 1,127 shares worth more than $553,358.50. The most recent insider tranaction occured on February, 7th when Director Ramiro G Peru sold 753 shares worth more than $376,500.00. Insiders at Elevance Health own 0.4% of the company. Learn More about insider trades at Elevance Health.

Information on this page was last updated on 2/7/2024.

Craig E. Samitt Insider Trading History at Elevance Health

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
7/26/2018Sell19,541$246.68$4,820,373.8820,857View SEC Filing Icon  
See Full Table

Craig E. Samitt Buying and Selling Activity at Elevance Health

This chart shows Craig E Samitt's buying and selling at Elevance Health by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Elevance Health Company Overview

Elevance Health logo
Elevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States. The company operates through four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It offers a variety of health plans and services to program members; health products; an array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, life, disability, and supplemental health insurance benefits. The company operates in the pharmacy services business; and markets and offers pharmacy services, including pharmacy benefit management, as well as home delivery and specialty pharmacies, claims adjudication, formulary management, pharmacy networks, rebate administration, a prescription drug database, and member services. In addition, it provides healthcare-related services and capabilities, including utilization management, behavioral health, integrated care delivery, palliative care, payment integrity services, subrogation services, and health and wellness programs, as well as services related to data management, information technology, and business operations. Further, the company is involved in the National Government Services business. The company provides its services under the Anthem Blue Cross and Blue Shield, Wellpoint, and Carelon brand names. The company was formerly known as Anthem, Inc. and changed its name to Elevance Health, Inc. in June 2022. Elevance Health, Inc. was incorporated in 2001 and is headquartered in Indianapolis, Indiana.
Read More

Today's Range

Now: $519.51
Low: $517.96
High: $521.18

50 Day Range

MA: $500.26
Low: $464.66
High: $516.97

2 Week Range

Now: $519.51
Low: $412.00
High: $521.18

Volume

288,219 shs

Average Volume

1,013,909 shs

Market Capitalization

$120.89 billion

P/E Ratio

20.64

Dividend Yield

1.26%

Beta

0.78